Hutch News

Hutch News

Stories tagged 'Stanley R Riddell'

Replenishing immune cells after remission

New approach, not yet tested in humans, aims to restore immune-powering B cells in cancer patients following successful CAR T-cell therapy

Oct. 17, 2016 | By Bill Briggs / Fred Hutch News Service

Scientists at Fred Hutch, Seattle Children’s Research Institute, and Technical University of Munich showed that activating a “kill switch” can turn off CAR T cells after doctors deem a cancer defeated, allowing normal B cells to again flourish.

View story >


Patients with advanced lymphoma in remission after T-cell therapy

New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission

Sept. 7, 2016 | By Susan Keown / Fred Hutch News Service

Seven of 11 trial participants who got a two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission, a new study found.

View story >


When do we say cure?

A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics

July 8, 2016 | By Rachel Tompa / Fred Hutch News Service

An individual patient may not hear the word "cure" on their oncologist's lips, but that doesn't mean the word has no meaning to researchers. It's just that it's very difficult to apply it to an individual person.

View story >


The cancer killers

Across research centers, scientists and innovators shelve competition to target a common enemy

June 15, 2016 | By Bill Briggs / Fred Hutch News Service

View story >


93 percent of advanced leukemia patients in remission after immunotherapy

‘Exciting’ but early results from trial of engineered immune cells

April 25, 2016 | By Susan Keown / Fred Hutch News Service

After her immune cells were genetically engineered to target her cancer, Kristin Kleinhofer's leukemia disappeared. The trial was her and her family's 'last hope'.

View story >


Hutch News

Vice President Joe Biden's Fred Hutch visit, dramatic remissions in immunotherapy trial, Doug Walker's life of service and more

April 1, 2016

Vice President Biden visits Fred Hutch, dramatic remissions in immunotherapy trial, Doug Walker's life of service, the link between cancer and bankruptcy, and more.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.